A citation-based method for searching scientific literature

Wilnelly Hernandez-Sanchez, Wei Huang, Brian Plucinsky, Nelson Garcia-Vazquez, Nathaniel J Robinson, William P Schiemann, Anthony J Berdis, Emmanuel Skordalakes, Derek J Taylor. PLoS Biol 2019
Times Cited: 5







List of co-cited articles
34 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Antitelomerase therapy provokes ALT and mitochondrial adaptive mechanisms in cancer.
Jian Hu, Soyoon Sarah Hwang, Marc Liesa, Boyi Gan, Ergun Sahin, Mariela Jaskelioff, Zhihu Ding, Haoqiang Ying, Adam T Boutin, Hailei Zhang,[...]. Cell 2012
176
60

Specific association of human telomerase activity with immortal cells and cancer.
N W Kim, M A Piatyszek, K R Prowse, C B Harley, M D West, P L Ho, G M Coviello, W E Wright, S L Weinrich, J W Shay. Science 1994
60

Induction of telomere dysfunction mediated by the telomerase substrate precursor 6-thio-2'-deoxyguanosine.
Ilgen Mender, Sergei Gryaznov, Z Gunnur Dikmen, Woodring E Wright, Jerry W Shay. Cancer Discov 2015
54
60

Hallmarks of cancer: the next generation.
Douglas Hanahan, Robert A Weinberg. Cell 2011
40

Altered telomeres in tumors with ATRX and DAXX mutations.
Christopher M Heaphy, Roeland F de Wilde, Yuchen Jiao, Alison P Klein, Barish H Edil, Chanjuan Shi, Chetan Bettegowda, Fausto J Rodriguez, Charles G Eberhart, Sachidanand Hebbar,[...]. Science 2011
613
40

The telomerase inhibitor imetelstat depletes cancer stem cells in breast and pancreatic cancer cell lines.
Immanual Joseph, Robert Tressler, Ekaterina Bassett, Calvin Harley, Christen M Buseman, Preeti Pattamatta, Woodring E Wright, Jerry W Shay, Ning F Go. Cancer Res 2010
92
40


Loss of Rap1 induces telomere recombination in the absence of NHEJ or a DNA damage signal.
Agnel Sfeir, Shaheen Kabir, Megan van Overbeek, Giulia B Celli, Titia de Lange. Science 2010
169
40

DNA C-circles are specific and quantifiable markers of alternative-lengthening-of-telomeres activity.
Jeremy D Henson, Ying Cao, Lily I Huschtscha, Andy C Chang, Amy Y M Au, Hilda A Pickett, Roger R Reddel. Nat Biotechnol 2009
260
40

Novel anticancer therapeutics targeting telomerase.
Maria Ruden, Neelu Puri. Cancer Treat Rev 2013
187
40

Telomerase as a Cancer Target. Development of New Molecules.
D L Mengual Gomez, R G Armando, C S Cerrudo, P D Ghiringhelli, D E Gomez. Curr Top Med Chem 2016
39
40

Cryo-EM structure of substrate-bound human telomerase holoenzyme.
Thi Hoang Duong Nguyen, Jane Tam, Robert A Wu, Basil J Greber, Daniel Toso, Eva Nogales, Kathleen Collins. Nature 2018
85
40

Recent advances in targeting the telomeric G-quadruplex DNA sequence with small molecules as a strategy for anticancer therapies.
Mohammad K Islam, Paul Jm Jackson, Khondaker M Rahman, David E Thurston. Future Med Chem 2016
27
40

A highly selective telomerase inhibitor limiting human cancer cell proliferation.
K Damm, U Hemmann, P Garin-Chesa, N Hauel, I Kauffmann, H Priepke, C Niestroj, C Daiber, B Enenkel, B Guilliard,[...]. EMBO J 2001
305
40

Shelterin-Mediated Telomere Protection.
Titia de Lange. Annu Rev Genet 2018
181
40

New prospects for targeting telomerase beyond the telomere.
Greg M Arndt, Karen L MacKenzie. Nat Rev Cancer 2016
60
40

Targeted Covalent Inhibition of Telomerase.
Rick C Betori, Yue Liu, Rama K Mishra, Scott B Cohen, Stephen J Kron, Karl A Scheidt. ACS Chem Biol 2020
4
50

Roles of telomeres and telomerase in cancer, and advances in telomerase-targeted therapies.
Mohammad A Jafri, Shakeel A Ansari, Mohammed H Alqahtani, Jerry W Shay. Genome Med 2016
202
40

Structure of the Tribolium castaneum telomerase catalytic subunit TERT.
Andrew J Gillis, Anthony P Schuller, Emmanuel Skordalakes. Nature 2008
188
40

The POT1-TPP1 telomere complex is a telomerase processivity factor.
Feng Wang, Elaine R Podell, Arthur J Zaug, Yuting Yang, Paul Baciu, Thomas R Cech, Ming Lei. Nature 2007
452
40

Telomerase as tumor marker.
Eiso Hiyama, Keiko Hiyama. Cancer Lett 2003
126
40



Telomerase-Mediated Strategy for Overcoming Non-Small Cell Lung Cancer Targeted Therapy and Chemotherapy Resistance.
Ilgen Mender, Ryan LaRanger, Krishna Luitel, Michael Peyton, Luc Girard, Tsung-Po Lai, Kimberly Batten, Crystal Cornelius, Maithili P Dalvi, Michael Ramirez,[...]. Neoplasia 2018
14
40

Telomerase-Targeted Cancer Immunotherapy.
Eishiro Mizukoshi, Shuichi Kaneko. Int J Mol Sci 2019
24
40

Functional interaction between telomere protein TPP1 and telomerase.
Arthur J Zaug, Elaine R Podell, Jayakrishnan Nandakumar, Thomas R Cech. Genes Dev 2010
81
40

Optimized tumor cryptic peptides: the basis for universal neo-antigen-like tumor vaccines.
Jeanne Menez-Jamet, Catherine Gallou, Aude Rougeot, Kostas Kosmatopoulos. Ann Transl Med 2016
17
40

Induced Telomere Damage to Treat Telomerase Expressing Therapy-Resistant Pediatric Brain Tumors.
Satarupa Sengupta, Matthew Sobo, Kyungwoo Lee, Shiva Senthil Kumar, Angela R White, Ilgen Mender, Christine Fuller, Lionel M L Chow, Maryam Fouladi, Jerry W Shay,[...]. Mol Cancer Ther 2018
19
40

ATR-X syndrome protein targets tandem repeats and influences allele-specific expression in a size-dependent manner.
Martin J Law, Karen M Lower, Hsiao P J Voon, Jim R Hughes, David Garrick, Vip Viprakasit, Matthew Mitson, Marco De Gobbi, Marco Marra, Andrew Morris,[...]. Cell 2010
245
40

Five dysfunctional telomeres predict onset of senescence in human cells.
Zeenia Kaul, Anthony J Cesare, Lily I Huschtscha, Axel A Neumann, Roger R Reddel. EMBO Rep 2011
120
40

Systematic analysis of telomere length and somatic alterations in 31 cancer types.
Floris P Barthel, Wei Wei, Ming Tang, Emmanuel Martinez-Ledesma, Xin Hu, Samirkumar B Amin, Kadir C Akdemir, Sahil Seth, Xingzhi Song, Qianghu Wang,[...]. Nat Genet 2017
191
40

Inhibition of telomerase limits the growth of human cancer cells.
W C Hahn, S A Stewart, M W Brooks, S G York, E Eaton, A Kurachi, R L Beijersbergen, J H Knoll, M Meyerson, R A Weinberg. Nat Med 1999
843
40


In vivo inhibition of lung cancer by GRN163L: a novel human telomerase inhibitor.
Z Gunnur Dikmen, Ginelle C Gellert, Shalmica Jackson, Sergei Gryaznov, Robert Tressler, Pakize Dogan, Woodring E Wright, Jerry W Shay. Cancer Res 2005
171
20

Break-induced telomere synthesis underlies alternative telomere maintenance.
Robert L Dilley, Priyanka Verma, Nam Woo Cho, Harrison D Winters, Anne R Wondisford, Roger A Greenberg. Nature 2016
182
20

Telomerase-negative immortalized human cells contain a novel type of promyelocytic leukemia (PML) body.
T R Yeager, A A Neumann, A Englezou, L I Huschtscha, J R Noble, R R Reddel. Cancer Res 1999
488
20

An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients.
Balazs Györffy, Andras Lanczky, Aron C Eklund, Carsten Denkert, Jan Budczies, Qiyuan Li, Zoltan Szallasi. Breast Cancer Res Treat 2010
20

Telomere shortening triggers senescence of human cells through a pathway involving ATM, p53, and p21(CIP1), but not p16(INK4a).
Utz Herbig, Wendy A Jobling, Benjamin P C Chen, David J Chen, John M Sedivy. Mol Cell 2004
812
20

Administration of a Nucleoside Analog Promotes Cancer Cell Death in a Telomerase-Dependent Manner.
Xuehuo Zeng, Wilnelly Hernandez-Sanchez, Mengyuan Xu, Tawna L Whited, Diane Baus, Junran Zhang, Anthony J Berdis, Derek J Taylor. Cell Rep 2018
7
20

Telomerase inhibition in a mouse cell line with long telomeres leads to rapid telomerase reactivation.
Delphine T Marie-Egyptienne, Marie Eve Brault, Shusen Zhu, Chantal Autexier. Exp Cell Res 2008
9
20

BLM and SLX4 play opposing roles in recombination-dependent replication at human telomeres.
Alexander P Sobinoff, Joshua Am Allen, Axel A Neumann, Sile F Yang, Monica E Walsh, Jeremy D Henson, Roger R Reddel, Hilda A Pickett. EMBO J 2017
60
20

Telomere and Telomerase Therapeutics in Cancer.
Yucheng Xu, Amir Goldkorn. Genes (Basel) 2016
53
20

The lncRNA BORG Drives Breast Cancer Metastasis and Disease Recurrence.
Alex J Gooding, Bing Zhang, Fereshteh Kenari Jahanbani, Hannah L Gilmore, Jenny C Chang, Saba Valadkhan, William P Schiemann. Sci Rep 2017
44
20


CHOPCHOP v2: a web tool for the next generation of CRISPR genome engineering.
Kornel Labun, Tessa G Montague, James A Gagnon, Summer B Thyme, Eivind Valen. Nucleic Acids Res 2016
381
20


SLX4IP Antagonizes Promiscuous BLM Activity during ALT Maintenance.
Stephanie Panier, Marija Maric, Graeme Hewitt, Emily Mason-Osann, Himabindu Gali, Anqi Dai, Adam Labadorf, Jean-Hugues Guervilly, Philip Ruis, Sandra Segura-Bayona,[...]. Mol Cell 2019
23
20

The alternative lengthening of telomeres phenotype in breast carcinoma is associated with HER-2 overexpression.
Andrea Proctor Subhawong, Christopher M Heaphy, Pedram Argani, Yuko Konishi, Nina Kouprina, Hind Nassar, Russell Vang, Alan K Meeker. Mod Pathol 2009
31
20

Genome-scale CRISPR-Cas9 knockout screening in human cells.
Ophir Shalem, Neville E Sanjana, Ella Hartenian, Xi Shi, David A Scott, Tarjei Mikkelson, Dirk Heckl, Benjamin L Ebert, David E Root, John G Doench,[...]. Science 2014
20


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.